Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab (Q56777007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

1 reference

José Luís Passos Coelho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Mafalda Oliveira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sofia Braga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Ricardo Fonseca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

João Oliveira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

English

0 references

publication date

3 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

841-844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-011-1417-2

24 January 2020

exact match

0 references

cites work

Leptomeningeal carcinomatosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Meningeal carcinomatosis in HER2-overexpressing breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1417-2

10.1007/S10549-011-1417-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21369716%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference